Coherus Biosciences | CHRS - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
ALKERMES USD 662.09M 62.59M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amarin USD 164.2M 15.45M 2026-06
Amgen USD 25.5B 547M 2026-06
Baxter International USD 3.59B 102M 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Fujifilm JPY 1.26T 57.74B 2026-03
Gilead Sciences USD 11.02B 1.54B 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Merck USD 27.73B 786M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Xencor USD 81.86M 8.41M 2026-06
Zoetis USD 2.06B 8M 2026-06